These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 10083335
1. Involvement of protein tyrosine phosphorylation in immunotoxin effects on T lymphocytes. Hamawy MM, Tsuchida M, Fechner JH, Manthei E, Knechtle SJ. Transplant Proc; 1999; 31(1-2):785. PubMed ID: 10083335 [No Abstract] [Full Text] [Related]
2. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18. Hamawy MM, Tsuchida M, Cho CS, Manthei ER, Fechner JH, Knechtle SJ. Transplantation; 2001 Aug 15; 72(3):496-503. PubMed ID: 11502982 [Abstract] [Full Text] [Related]
3. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment. Matar AJ, Pathiraja V, Wang Z, Duran-Struuck R, Gusha A, Crepeau R, Tasaki M, Sachs DH, Huang CA. Transpl Immunol; 2012 Aug 15; 27(1):52-4. PubMed ID: 22676970 [Abstract] [Full Text] [Related]
4. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice. Weetall M, Digan ME, Hugo R, Mathew S, Hopf C, Tart-Risher N, Zhang J, Shi V, Fu F, Hammond-McKibben D, West S, Brack R, Brinkmann V, Bergman R, Neville D, Lake P. Transplantation; 2002 May 27; 73(10):1658-66. PubMed ID: 12042656 [Abstract] [Full Text] [Related]
5. Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies. Hamawy MM, Tsuchida M, Manthei ER, Dong Y, Fechner JE, Knechtle JS. Transplantation; 1999 Sep 15; 68(5):693-8. PubMed ID: 10507490 [Abstract] [Full Text] [Related]
6. The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro. Meng G, Jiang Y, Hubbard W, Thomas JM. Transpl Immunol; 1998 Mar 15; 6(1):53-9. PubMed ID: 9640629 [Abstract] [Full Text] [Related]
7. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. Fechner JH, Vargo DJ, Geissler EK, Wang J, Neville DM, Knechtle SJ. Transplant Proc; 1997 Mar 15; 29(1-2):1158. PubMed ID: 9123249 [No Abstract] [Full Text] [Related]
8. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Torrealba JR, Fernandez LA, Kanmaz T, Oberley TD, Schultz JM, Brunner KG, Peters D, Fechner JH, Dong Y, Hu H, Hamawy MM, Knechtle SJ. Transplantation; 2003 Aug 15; 76(3):524-30. PubMed ID: 12923438 [Abstract] [Full Text] [Related]
9. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. Neville DM, Scharff J, Hu HZ, Rigaut K, Shiloach J, Slingerland W, Jonker M. J Immunother Emphasis Tumor Immunol; 1996 Mar 15; 19(2):85-92. PubMed ID: 8732691 [Abstract] [Full Text] [Related]
10. Reversal of acute allograft rejection using immunotoxin. Knechtle SJ, Fechner JH, Stavrou S, Neville DM, Dong Y, Hong X, Tsuchida M, Hamawy MM. Transplant Proc; 1998 Aug 15; 30(5):2150-1. PubMed ID: 9723422 [No Abstract] [Full Text] [Related]
11. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv. Wang Z, Kim GB, Woo JH, Liu YY, Mathias A, Stavrou S, Neville DM. Bioconjug Chem; 2007 Aug 15; 18(3):947-55. PubMed ID: 17352456 [Abstract] [Full Text] [Related]
12. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, Krueger JG. Nat Med; 1995 May 15; 1(5):442-7. PubMed ID: 7585092 [Abstract] [Full Text] [Related]
13. Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4+ Treg in nonhuman primates. Wang Z, Louras NJ, Lellouch AG, Pratts SG, Zhang H, Wang H, Huang CA, Cetrulo CL, Madsen JC, Sachs DH, Wang Z. Mol Oncol; 2018 Aug 15; 12(8):1374-1382. PubMed ID: 29873181 [Abstract] [Full Text] [Related]
14. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Fechner JH, Vargo DJ, Geissler EK, Graeb C, Wang J, Hanaway MJ, Watkins DI, Piekarczyk M, Neville DM, Knechtle SJ. Transplantation; 1997 May 15; 63(9):1339-45. PubMed ID: 9158030 [Abstract] [Full Text] [Related]
15. Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation. Walz G, Zanker B, Brand K, Waters C, Genbauffe F, Zeldis JB, Murphy JR, Strom TB. Proc Natl Acad Sci U S A; 1989 Dec 15; 86(23):9485-8. PubMed ID: 2594781 [Abstract] [Full Text] [Related]
16. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Greenfield L, Johnson VG, Youle RJ. Science; 1987 Oct 23; 238(4826):536-9. PubMed ID: 3498987 [Abstract] [Full Text] [Related]
17. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J. Glycobiology; 2000 Feb 23; 10(2):131-40. PubMed ID: 10642604 [Abstract] [Full Text] [Related]
18. Toward preclinical studies with anti-CD86 immunotoxin. Otten HG, Ossevoort M, Vooijs WC, van der Gouw AP, de Boer M, de Gast GC. Transplant Proc; 1999 Feb 23; 31(1-2):1236. PubMed ID: 10083551 [No Abstract] [Full Text] [Related]
19. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques. Hubbard WJ, Moore JK, Contreras JL, Smyth CA, Chen ZW, Lobashevsky AL, Nagata K, Neville DM, Thomas JM. Hum Immunol; 2001 May 23; 62(5):479-87. PubMed ID: 11334671 [Abstract] [Full Text] [Related]
20. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes. Bousvaros A, Stevens AC, Strom TB, Murphy J, Lamont JT. Dig Dis Sci; 1997 Jul 23; 42(7):1542-8. PubMed ID: 9246061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]